miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy.
Iga DziechciowskaMałgorzata DąbrowskaAnna MizielskaNatalia PyraNatalia LisiakPrzemysław KopczyńskiMagdalena Jankowska-WajdaBłażej RubiśPublished in: Current issues in molecular biology (2023)
Breast cancer is one of the most commonly diagnosed cancer types worldwide. Regarding molecular characteristics and classification, it is a heterogeneous disease, which makes it more challenging to diagnose. As is commonly known, early detection plays a pivotal role in decreasing mortality and providing a better prognosis for all patients. Different treatment strategies can be adjusted based on tumor progression and molecular characteristics, including personalized therapies. However, dealing with resistance to drugs and recurrence is a challenge. The therapeutic options are limited and can still lead to poor clinical outcomes. This review aims to shed light on the current perspective on the role of miRNAs in breast cancer diagnostics, characteristics, and prognosis. We discuss the potential role of selected non-coding RNAs most commonly associated with breast cancer. These include miR-21, miR-106a, miR-155, miR-141, let-7c, miR-335, miR-126, miR-199a, miR-101, and miR-9, which are perceived as potential biomarkers in breast cancer prognosis, diagnostics, and treatment response monitoring. As miRNAs differ in expression levels in different types of cancer, they may provide novel cancer therapy strategies. However, some limitations regarding dynamic alterations, tissue-specific profiles, and detection methods must also be raised.
Keyphrases
- cell proliferation
- long non coding rna
- long noncoding rna
- poor prognosis
- cancer therapy
- gene expression
- type diabetes
- endothelial cells
- squamous cell carcinoma
- stem cells
- dna methylation
- machine learning
- cardiovascular disease
- newly diagnosed
- coronary artery disease
- mental health
- end stage renal disease
- risk factors
- deep learning
- mesenchymal stem cells
- cardiovascular events
- social support
- childhood cancer
- free survival